Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.
[This corrects the article DOI: 10.1371/journal.pone.0166415.].
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5313219?pdf=render |
| id |
doaj-9692a480892a426c8cb616c32f12fcdd |
|---|---|
| record_format |
Article |
| spelling |
doaj-9692a480892a426c8cb616c32f12fcdd2020-11-25T01:57:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017277510.1371/journal.pone.0172775Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.PLOS ONE Staff[This corrects the article DOI: 10.1371/journal.pone.0166415.].http://europepmc.org/articles/PMC5313219?pdf=render |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
PLOS ONE Staff |
| spellingShingle |
PLOS ONE Staff Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. PLoS ONE |
| author_facet |
PLOS ONE Staff |
| author_sort |
PLOS ONE Staff |
| title |
Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. |
| title_short |
Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. |
| title_full |
Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. |
| title_fullStr |
Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. |
| title_full_unstemmed |
Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. |
| title_sort |
correction: an anti-parkinson's disease drug via targeting adenosine a2a receptor enhances amyloid-β generation and γ-secretase activity. |
| publisher |
Public Library of Science (PLoS) |
| series |
PLoS ONE |
| issn |
1932-6203 |
| publishDate |
2017-01-01 |
| description |
[This corrects the article DOI: 10.1371/journal.pone.0166415.]. |
| url |
http://europepmc.org/articles/PMC5313219?pdf=render |
| work_keys_str_mv |
AT plosonestaff correctionanantiparkinsonsdiseasedrugviatargetingadenosinea2areceptorenhancesamyloidbgenerationandgsecretaseactivity |
| _version_ |
1724976366488649728 |